DE69023394D1 - Chelat-Derivate von atrialnatriurethischem Faktor (ANF). - Google Patents

Chelat-Derivate von atrialnatriurethischem Faktor (ANF).

Info

Publication number
DE69023394D1
DE69023394D1 DE69023394T DE69023394T DE69023394D1 DE 69023394 D1 DE69023394 D1 DE 69023394D1 DE 69023394 T DE69023394 T DE 69023394T DE 69023394 T DE69023394 T DE 69023394T DE 69023394 D1 DE69023394 D1 DE 69023394D1
Authority
DE
Germany
Prior art keywords
natriurethic
anf
atrial
factor
chelate derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69023394T
Other languages
English (en)
Other versions
DE69023394T2 (de
Inventor
Richard J Flanagan
F Peter Charleson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of DE69023394D1 publication Critical patent/DE69023394D1/de
Publication of DE69023394T2 publication Critical patent/DE69023394T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69023394T 1989-06-16 1990-06-13 Chelat-Derivate von atrialnatriurethischem Faktor (ANF). Expired - Fee Related DE69023394T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36716989A 1989-06-16 1989-06-16

Publications (2)

Publication Number Publication Date
DE69023394D1 true DE69023394D1 (de) 1995-12-14
DE69023394T2 DE69023394T2 (de) 1996-07-04

Family

ID=23446176

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69023394T Expired - Fee Related DE69023394T2 (de) 1989-06-16 1990-06-13 Chelat-Derivate von atrialnatriurethischem Faktor (ANF).

Country Status (4)

Country Link
EP (1) EP0403243B1 (de)
JP (1) JP2512604B2 (de)
CA (1) CA2019035C (de)
DE (1) DE69023394T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
CA2131816C (en) * 1992-03-13 2001-08-28 Richard T. Dean Technetium-99m labeled peptides for imaging inflammation
US5989519A (en) * 1992-03-13 1999-11-23 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
CN1137267A (zh) * 1993-12-16 1996-12-04 西巴-盖尔基股份公司 用作螯合剂的n，n′-二(2-羟基苄基)-乙二胺n，n′-二乙酸衍生物
GB9401483D0 (en) * 1994-01-26 1994-03-23 Sandoz Ltd Organic compounds
DE19536783A1 (de) * 1995-09-21 1997-03-27 Diagnostikforschung Inst Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609725A (en) * 1984-10-09 1986-09-02 Merck & Co., Inc. Cardiac atrial peptides
JPS61161299A (ja) * 1985-01-04 1986-07-21 メルク　エンド　カムパニ−　インコ−ポレ−テツド 心房ペプチド
EP0244169A3 (de) * 1986-04-29 1990-04-11 Merck & Co. Inc. Peptide mit ANF-Wirksamkeit
AU619218B2 (en) * 1987-11-06 1992-01-23 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions

Also Published As

Publication number Publication date
JP2512604B2 (ja) 1996-07-03
EP0403243A1 (de) 1990-12-19
JPH0381295A (ja) 1991-04-05
DE69023394T2 (de) 1996-07-04
CA2019035A1 (en) 1990-12-16
EP0403243B1 (de) 1995-11-08
CA2019035C (en) 1999-11-30

Similar Documents

Publication Publication Date Title
NO885339D0 (no) Leukemi-inhiberende faktor.
AT399720B (de) Gewinnung von amphiregulin durch gentechnische verfahren
PT88497A (pt) Verfahren und geraet vollautomatischen reinigen von farb-oder lackverschmutzten spritzpistolen
DE68910145D1 (de) Verfahren zur Herstellung von Azolylmethyl-cyclopentanol-Derivaten.
DE68914178D1 (de) Elektroumstrahlprüfung von elektronischen Komponenten.
DE68908185D1 (de) Chelat-zusammensetzung.
DE68921870D1 (de) Verfahren zur Reduktion von Stickoxiden.
FI880020A (fi) Vaesentigen ren cytotoxitet utloesande faktor.
DE69023394D1 (de) Chelat-Derivate von atrialnatriurethischem Faktor (ANF).
DE68912160D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten.
FI885055A (fi) Celltillvaext inhiberande faktor.
DE58907083D1 (de) Verfahren zur Herstellung von Benztriazolderivaten.
DE68910188D1 (de) Verfahren zur Standardisierung von Spektrallinien.
DE68918602D1 (de) Elektroanalytisches Verfahren.
DE68921582D1 (de) Verfahren zur Herstellung von funktionellen Isothiocyanatometallkomplexen.
DE68924225D1 (de) Verfahren zur Erhöhung der Wiederbenetzbarkeit von Textilien.
DE69003075D1 (de) Stabilisierungszusammensetzungen.
DK278688D0 (da) Anf-derivater
DE69018597D1 (de) Herstellung von Messbändern.
FI920423A0 (fi) Foerbaettringar i skaeranordning.
DE69024193D1 (de) Ascorbinsäure-derivate
IT9019977A0 (it) Superleghe contenenti tantalio
DE68923159D1 (de) Verfahren zur Herstellung von 1,4-Dihydropyridin-Derivaten.
DE69010271D1 (de) Regenerierung von verbrauchten Ferrichlorid-Ätzmitteln.
DE69018816D1 (de) Aminosäurederivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA & CO, KIRKLAND, QUEBEC, CA

8339 Ceased/non-payment of the annual fee